Improving the safety of immunotherapy

Matthew A Rank, David I. Bernstein

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We present a 42-year-old woman who experienced a systemic reaction (SR) after a subcutaneous immunotherapy (SCIT) injection. Her physician must make a decision, along with the patient, on how to proceed. We consider the medical evidence pertinent to specific risk factors for SRs to SCIT, including asthma control, concomitant medications and new medical diagnoses, the influence of pollen season, adjustments for large local reactions, initial testing results, type of buildup protocol, and administration and dosing errors. We next discuss the potential risk-mitigating actions that the patient and provider should consider and the available evidence that supports various approaches, including cessation of SCIT, decreasing allergen dose or altering the timing of injections, initiating or changing the medical pretreatment regimen, and changing to sublingual immunotherapy, and also the role for anaphylaxis preparedness. Finally, we highlight the key knowledge gaps identified in this review and provide management recommendations for this 42-year-old woman.

Original languageEnglish (US)
Pages (from-to)131-135
Number of pages5
JournalJournal of Allergy and Clinical Immunology: In Practice
Volume2
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Immunotherapy
Sublingual Immunotherapy
Immunologic Desensitization
Safety
Anaphylaxis
Subcutaneous Injections
Pollen
Asthma
Physicians
Injections

Keywords

  • Desensitization
  • Hypersensitivity
  • Immunologic
  • Immunotherapy

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Improving the safety of immunotherapy. / Rank, Matthew A; Bernstein, David I.

In: Journal of Allergy and Clinical Immunology: In Practice, Vol. 2, No. 2, 2014, p. 131-135.

Research output: Contribution to journalArticle

@article{c02944a8fabf46a48029ad3e7c5f5831,
title = "Improving the safety of immunotherapy",
abstract = "We present a 42-year-old woman who experienced a systemic reaction (SR) after a subcutaneous immunotherapy (SCIT) injection. Her physician must make a decision, along with the patient, on how to proceed. We consider the medical evidence pertinent to specific risk factors for SRs to SCIT, including asthma control, concomitant medications and new medical diagnoses, the influence of pollen season, adjustments for large local reactions, initial testing results, type of buildup protocol, and administration and dosing errors. We next discuss the potential risk-mitigating actions that the patient and provider should consider and the available evidence that supports various approaches, including cessation of SCIT, decreasing allergen dose or altering the timing of injections, initiating or changing the medical pretreatment regimen, and changing to sublingual immunotherapy, and also the role for anaphylaxis preparedness. Finally, we highlight the key knowledge gaps identified in this review and provide management recommendations for this 42-year-old woman.",
keywords = "Desensitization, Hypersensitivity, Immunologic, Immunotherapy",
author = "Rank, {Matthew A} and Bernstein, {David I.}",
year = "2014",
doi = "10.1016/j.jaip.2013.09.017",
language = "English (US)",
volume = "2",
pages = "131--135",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Improving the safety of immunotherapy

AU - Rank, Matthew A

AU - Bernstein, David I.

PY - 2014

Y1 - 2014

N2 - We present a 42-year-old woman who experienced a systemic reaction (SR) after a subcutaneous immunotherapy (SCIT) injection. Her physician must make a decision, along with the patient, on how to proceed. We consider the medical evidence pertinent to specific risk factors for SRs to SCIT, including asthma control, concomitant medications and new medical diagnoses, the influence of pollen season, adjustments for large local reactions, initial testing results, type of buildup protocol, and administration and dosing errors. We next discuss the potential risk-mitigating actions that the patient and provider should consider and the available evidence that supports various approaches, including cessation of SCIT, decreasing allergen dose or altering the timing of injections, initiating or changing the medical pretreatment regimen, and changing to sublingual immunotherapy, and also the role for anaphylaxis preparedness. Finally, we highlight the key knowledge gaps identified in this review and provide management recommendations for this 42-year-old woman.

AB - We present a 42-year-old woman who experienced a systemic reaction (SR) after a subcutaneous immunotherapy (SCIT) injection. Her physician must make a decision, along with the patient, on how to proceed. We consider the medical evidence pertinent to specific risk factors for SRs to SCIT, including asthma control, concomitant medications and new medical diagnoses, the influence of pollen season, adjustments for large local reactions, initial testing results, type of buildup protocol, and administration and dosing errors. We next discuss the potential risk-mitigating actions that the patient and provider should consider and the available evidence that supports various approaches, including cessation of SCIT, decreasing allergen dose or altering the timing of injections, initiating or changing the medical pretreatment regimen, and changing to sublingual immunotherapy, and also the role for anaphylaxis preparedness. Finally, we highlight the key knowledge gaps identified in this review and provide management recommendations for this 42-year-old woman.

KW - Desensitization

KW - Hypersensitivity

KW - Immunologic

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=84895451753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895451753&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2013.09.017

DO - 10.1016/j.jaip.2013.09.017

M3 - Article

C2 - 24607038

AN - SCOPUS:84895451753

VL - 2

SP - 131

EP - 135

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

SN - 2213-2198

IS - 2

ER -